Sponsor Pipeline

National Institute of Blood and Marrow Transplant (NIBMT), Pakistan Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
1
Recruiting
5
Disease Areas
Active Trials by Phase
Phase 2
2
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06490627 Unraveling the Impact of Thalidomide at Diverse Doses in Transfusion Dependent Beta… Fetal Hemoglobin Recruiting
NCT06490601 Long Term Beta Thalassemia Treatment: Findings From The Extension Period Fetal Hemoglobin Active, Not Recruiting
Phase 1/2
NCT06764329 The Effectiveness of Allogenic Mesenchymal Stem Cells Therapy on Hair Regrowth in… Androgenetic Alopecia Enrolling by Invitation
NCT06888973 Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases Rheumatoid Arthritis Enrolling by Invitation
Disease Areas
Thalassemia (2) Rheumatoid Arthritis (1) Lupus (SLE) (1) Ankylosing Spondylitis (1) Scleroderma (1)
Get alerts when National Institute of Blood and Marrow Transplant (NIBMT), Pakistan's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free